Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, is a young entrepreneur who founded Biotricity after working in technology and finance and has a background in computer engineering. Today, he discusses their suite of devices and software for real time remote cardiac monitoring and cardiac-oriented telehealth. Bioflux ® is Biotricity’s core product which is a comprehensive mobile cardiac telemetry (MCT) solution encompassing a device, software, and 24/7 monitoring that integrates seamlessly into cardiologists’ existing systems. This allows physicians to see more patients, perform more procedures, and identify which patients need more time and attention.
Waqaas, the founder and CEO of Biotricity, is a serial entrepreneur, a former investment advisor and an expert in wireless communication technology.
Waqaas has held several high-level design positions in IBM, AMD, and Intel. His achievements have been numerous in both the technical and academic worlds. Combined with this,
Waqaas has extensive experience in board and executive roles within start-ups, mid-sized companies, and non-profits.
Academically, he was distinguished for his various innovative designs in digital, analog, embedded, and micro-electro-mechanical products. His work was published in various conferences such as IEEE and the National Communication Council. Waqaas has a dual Bachelor’s degree in Computer Engineering and Economics, a Master’s in Computer Engineering from Rochester Institute of Technology, and a Master’s in Business Administration from Henley Business School. At the Henley Business School, he obtained his Doctorate in Business with a specialty in Transformative Innovations and Billion Dollar Markets.